Experimental models of colorectal cancer

Diseases of the Colon and Rectum

Volumn 41, Issue 4, 1998, Pages 490-505

  Banerjee, Anjan ^a,b   Quirke, Philip ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Halifax Royal Infirmary   (United Kingdom)

Author keywords

Bile acid; Cancer; Carcinogen; Cell lines; Colorectal

Indexed keywords

AZOXYMETHANE; CARCINOGEN; DIMETHYLHYDRAZINE; METHYLNITRONITROSOGUANIDINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; EXPERIMENTAL MODEL; GENE EXPRESSION; GENETIC MODEL; INTESTINE BYPASS; METASTASIS; MOUSE; MULTIDRUG RESISTANCE; MUTAGENESIS; NONHUMAN; RAT; STOMACH SURGERY; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOGENS; CELLS, CULTURED; COCARCINOGENESIS; COLORECTAL NEOPLASMS; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; NEOPLASM METASTASIS; SURGICAL PROCEDURES, OPERATIVE; WOUNDS AND INJURIES;

EID: 0031894880     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02235764     Document Type: Article

References (168)

1. Lorenz E, Stewart HL. Intestinal carcinoma and other lesions in mice following oral administration of 1,2,5,6-dibenzathracene and 2-0-methylcholanthrene. J Natl Cancer Inst 1941;1:17-40.
2. Walpole AL, Williams M, Roberts DC. The carcinogenic action of the carcinogenic action of 4-aminodiphenyl and 3:2-dimethyl-4-aminodiphenyl. Br J Ind Med 1952;9;255-63.
3. Cleveland JC, Litvak SF, Cole JW. Identification of the route of action of the carcinogen 3:2-dimethyl-4-amino-diphenyl in the induction of intestinal neoplasia. Cancer Res 1967;27:708-14.
4. Navarrete A, Spjut H. Effect of colostomy on experimentally produced neoplasms of the colon of the rat. Lancet 1967;2:1466-72.
5. Laqueur GL. The induction of intestinal neoplasms in rats with the glycoside cycasin and its aglycone. Virchows Arch Pathol Anat Histopathol 1965;340:151-63.
6. Druckrey H, Lange A. Carcinogenicity of azoxymethane dependent on age in BD rats. Fed Proc 1972;31: 1482-4.
7. Ryser HJ. Chemical carcinogenesis. N Engl J Med 1971; 285:721-34.
8. Wiebecke B, Krey U, Loehrs U, Eder M. Morphological and autoradiographical investigations on experimental carcinogenesis and polyp development in the intestinal tract of rats and mice. Virchows Arch A Pathol Anat Histopathol 1973;360:179-93.
9. Balish E, Shih CN, Croft WA, et al. Effect of age, sex and intestinal flora on the induction of colon tumours in rats. J Natl Cancer Inst 1977;58:1103-6.
10. Evans JT, Shows TB, Sproul EE, Paolini NS, Mittelman A, Hauschka TS. Genetics of colon carcinogenesis in mice treated with 1,2-dimethylhydrazine. Cancer Res 1977;37:134-6.
11. Moon RC, Fricks CM, Schiff LJ. Effect of age and sex on colon carcinogenesis. Proc Am Assoc Cancer Res 1976; 17:23-8.
12. Ward JM, Yamamoto RS, Brown CA. Pathology of intestinal neoplasms and other lesions in rats exposed to azoxymethane. J Natl Cancer Inst 1973;51:1029-39.
13. Fiala ES. Investigations into the metabolism and mode of action of the colon carcinogen 1,2-dimethylhydrazine. Cancer 1975;36:2407-12.
14. Grab DJ, Zedek MS. Organ specific effects of the carcinogen methylazoxymethanol related to metabolism by NAD-dependent dehydrogenases. Cancer Res 1977; 37:4182-7.
15. Thurnherr N, Deschner EE, Stonehill EH, Lipkin M. Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine. Cancer Res 1973;33:940-5.
16. Ward JM. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab Invest 1974;30:505-13.
17. Winneker RC, Tompkins M, Westenberger P, Harris J. Morphological studies of chemically induced colon tumours in hamsters. Exp Mol Pathol 1977;27:19-34.
18. Pozharisski KM, Kapustin YM, Likhachev AJ, Shaposhnikov JD. The mechanism of carcinogenic action of 1,2-dimethylhydrazine in rats. Int J Cancer 1975;15: 673-83.
19. Fiala ES, Bobotas G, Kulakis C, Wattenberg LW, WeisburgerJH. Effect of disulfiram and related compounds of the metabolism in vivo of the colon carcinogen 1,2-dimethylhydrazine. Biochem Pharmacol 1977;26: 1763-8.
20. Weisburger JH. Colon carcinogens: their metabolism and mode of action. Cancer 1971;28:60-70.
21. Zedek MS, Grab DJ, Sternberg SS. Differences in the acute response of the various segments of the rat intestine to treatment with the intestinal carcinogen methylazoxymethanol acetate. Cancer Res 1977;37: 32-6.
22. Sugimura T, Fujimura S, Baba T. Tumour production in the glandular stomach and alimentary tract of the rat by N-methyl-N-nitro-N-nitrosoguanidine. Cancer Res 1970;30:455-65.
23. Narisawa T, Sato T, Hayakawa M, Sakuma A, Nakano H. Carcinoma of the colon and rectum of rats by rectal infusion of N-methyl-N-nitro-N-nitrosoguanidine. Gann 1971;62:231-4.
24. Newberne PM, Rogers A. Rat colon carcinomas associated with aflatoxin and marginal vitamin A. J Natl Cancer Inst 1973;50:439-48.
25. Deger GE. Aflatoxin - human colon carcinogenesis [letter]? Ann Intern Med 1976;85:204.
26. Lamont JT, O'Gorman TA. Experimental colon cancer. Gastroenterology 1978;75:1157-69.
27. Lingeman CH, Garner FM. Comparative study of intestinal adenocarcinomas of animals and man. J Natl Cancer Inst 1972;48:325-46.
28. Madarnas P, Dube M, Rola-Pleszczynski M, Nigam VN. An animal model of Kaposi's sarcoma. II. Pathogenesis of dimethylhydrazine induced angiosarcoma and colorectal cancer in three mouse strains. Anticancer Res 1992;12:113-7.
29. Hawks A, Swann PF, Magee PN. Probable methylation of nucleic acids of mouse colon by 1,2-dimethylhydrazine in vivo. Biochem Pharmacol 1971; 21:432-5.
30. Hawks A, Magee PN. The alkylation of nucleic acids of rat and mouse in vivo by the carcinogen 1,2-dimethylhydrazine. Br J Cancer 1974;30:440-6.
31. Rogers KJ, Pegg AE. Formation of O6-methylguanine by alkylation of rat liver, colon and kidney DNA following administration of 1,2-dimethylhydrazine. Cancer Res 1977;37:4082-7.
32. Kanagalingam K, Balis EM. In vivo repair of rat intestinal DNA damage by alkylating agents. Cancer 1975; 36:2364-72.
33. Gennaro AR, Villanueva R, Sukonthaman Y, Vathanophas V, Rosemond GP. Chemical carcinogenesis in transposed intestinal segments. Cancer Res 1973;33: 536-41.
34. Chan PC, Cohen LA, Narisawa T, Weisburger JH. Early effects of a single intrarectal dose of 1,2-dimethylhydrazine in mice. Cancer Res 1976;36:13-7.
35. Maskens AP. Histogenesis and growth pattern of 1,2-dimethylhydrazine induced rat colon adenocarcinoma. Cancer Res 1976;36:1585-92.
36. Tutton PJ, Barkla DH. Cell proliferation in the descending colon of dimethylhydrazine treated rats and in dimethylhydrazine induced adenocarcinomata. Virchows Arch B Cell Pathol 1976;21:147-60.
37. Tutton PJ, Barkla DH. A comparison of cell proliferation in normal and neoplastic intestinal epithelia following either biogenic amine depletion or monoamine oxidase inhibition. Virchows Arch B Cell Pathol 1976; 21:161-8.
38. Tutton PJ, Barkla DH. The influence of adrenoceptor activity on cell proliferation in colonic crypt epithelium and in colonic adenocarcinoma. Virchows Arch Zell Pathol 1977;24:139-64.
39. Wattenberg LW. Inhibition of dimethylhydrazine induced neoplasia of the large intestine by disulfiram. J Natl Cancer Inst 1975;54:1005-6.
40. Jacobs MM, Burger J, Griffin AC. Inhibitory effects of selenium on 1,2-dimethylhydrazine and methylazoxymethanol acetate induction of colon tumors. Cancer Lett 1977;2:133-8.
41. Tutton PJ, Barkla DH. Cytotoxicity of 5,6-dihydroxytryptamine in dimethylhydrazine-induced carcinomas of rat colon. Cancer Res 1977;37:1241-4.
42. Filipe MI. Mucous secretion in rat colonic mucosa during carcinogenesis induced by dimethylhydrazine: a morphological and histochemical study. Br J Cancer 1975;32:60-77.
43. Filipe MI, Cooke KB. Changes in the composition of mucin in the mucosa adjacent to carcinoma of the colon as compared with the normal. J Clin Pathol 1974;27:315-22.
44. Filipe MI, Branfoot AC. Abnormal patterns of mucus secretion in apparently normal mucosa of large intestine with carcinoma. Cancer 1974;34:282-9.
45. Barkla DH, Tutton PH. Surface changes in the descending colon of rats treated with dimethylhydrazine. Cancer Res 1977;37:262-71.
46. Toth B, Malick L. Production of intestinal and other tumours by 1,2-dimethylhydrazine dihydrochloride in mice. II. Scanning electron microscopic and cytochemical study of colonic neoplasms. Br J Exp Pathol 1976; 57:696-705.
47. Homburger F, Hsueh SS, Kerr CS, Russfield AB. Inherited susceptibility of inbred strains of syrian hamsters to induction of subcutaneous sarcomas and mammary and gastrointestinal carcinomas by subcutaneous and gastric administration of polynuclear hydrocarbons. Cancer Res 1972;32:360-6.
48. Young GP, McIntyre A, Albert V, Folino M, Muir JG, Gibson PR. Wheat bran suppresses potato starch potentiated colorectal tumorigenesis at the aberrant crypt stage in a rat model. Gastroenterology 1996;110: 508-14.
49. McIntosh GH. Colon cancer: dietary modifications required for a balanced protective diet. Prev Med 1993; 22:767-74.
50. Morson BD. Evolution of cancer of the colon and rectum. Cancer 1974;343:845-60.
51. JM, Yamamoto RS, Benjamin T, Brown CA, Weisburger JH. Experimentally induced cancer of the colon in rats and mice. J Am Vet Med Assoc 1974;164:729-32.
52. Haase P, Cowen DM, Knowles JC, Cooper EH. Evaluation of dimethylhydrazine induced tumours in mice as a model system for colorectal cancer. Br J Cancer 1973;28:530-43.
53. LaMont JT, Weiser MM, Isselbacher KJ. Cell surface glycosyltransferase activity in normal and neoplastic intestinal epithelium of the rat. Cancer Res 1974;34: 3225-8.
54. Cook JW, Kennaway EL, Kennaway NM. Production of tumors in mice by deoxycholic acid [letter]. Nature 1940;145:627.
55. Lacassagne A, Buu-Hoi NP, Zaidela F. Carcinogenic activity of apocholic acid. Nature 1961;190:1007-8.
56. Narisawa T, Magadia NE, Weisburger JH, Wynder EL. Promoting effect of bile acids on colon carcinogenesis after intrarectal installation of N-methyl-N'-nitro-N-nitrosaguanidine in rats. J Natl Cancer Inst 1974;53: 1093-7.
57. Reddy BS, Narasawa T, Weisburger JH, Wynder EL. Promoting effect of sodium deoxycholate on colon adenocarcinomas in germ-free rats. J Natl Cancer Inst 1976;56:441-2.
58. Reddy BS, Watanabe K, Weisburger JH, Wynder EL. Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res 1977;37:3238-42.
59. Chomchai C, Bhadrachari N, Nigro ND. The effect of bile on the induction of experimental intestinal tumors in rats. Dis Colon Rectum 1974;17:310-2.
60. Nigro ND, Bhadrachari N, Chomchai C. A rat model for studying colon cancer. Effect of cholestyramine on induced tumors. Dis Colon Rectum 1973;16:438-43.
61. Reddy BS, Narisawa T, Weisburger JH. Colon carcinogenesis in germ-free rats with intrarectal 1,2-dimethylhydrazine and subcutaneous azoxymethane. Cancer Res 1975;36:2874-6.
62. Asano T, Pollard M, Madsen DC. Effects of cholestyramine on 1,2-dimethylhydrazine-induced enteric carcinoma in germ-free rats. Proc Soc Exp Biol Med 1975; 150:780-5.
63. Imray CH, Minoura T, Davis A, et al. Comparability of hamster with human faecal unconjugated bile acids in a model of colorectal cancer. Anticancer Res 1992;12: 553-8.
64. Pozharisski KM. The significance of nonspecific injury for colon carcinogenesis in rats. Cancer Res 1975;35: 3824-30.
65. Ward JM, Yamamoto RS, Weisburger JH. Cellulose dietary bulk and azoxymethane-induced intestinal cancer. J Natl Cancer Inst 1973;5:713-5.
66. Cleveland JC, Cole JW. Relationship of experimentally induced intestinal tumors to laxative ingestion. Cancer 1969;23:1200-3.
67. Kim YS, Isaacs R, Perdomo J. Alterations of membrane glycopeptides in human colonic adenocarcinoma. Proc Natl Acad Sci U S A 1974;71:4869-73.
68. LaMont JT, Isselbacher KJ. Alterations in glycosyltransferase in human colon cancer. J Natl Cancer Inst 1975; 54:53-6.
69. Garmaise AB, Rogers AE, Sarvaris CA, Zamcheck N, Newberne PM. Immunologic aspects of 1,2-dimethylhydrazine-induced colon tumors in rats. J Natl Cancer Inst 1975;54:1231-5.
70. Martin F, Martin MS, Bordes M, Knobel S. Antigens associated with chemically induced intestinal carcinomas of rats. Int J Cancer 1975;15:144-51.
71. Steele G, Sjoegren HO. Cross-reacting tumor-associated antigen(s) among chemically induced rat colon carcinomas. Cancer Res 1974;34:1801-7.
72. Steele G, Sjoegren HO. Embryonic antigens associated with chemically induced colon carcinomas in rats. Int J Cancer 1974;14:435-44.
73. Byrne PJ, Stephens RB, Hennessy TP, West AB, Sheahan DG. Colon cancer at sites of anastomosis [letter]. Lancet 1984;1:225.
74. Byrne PJ, Stephens RB, West B, O'Regan M, Hennessy TP. Handling of the bowel during surgery promotes tumour formation in an experimental model [abstract]. Br J Surg 1988;75:612.
75. Kanazawa K, Yamamoto T, Sato S. Experimental induction of colonic carcinomas in rats. Jpn J Exp Med 1975;45:439-56.
76. O'Donnell AF, O'Connell PR, Royston D, Johnston DH, Barnard R, Bouchier-Hayes D. Suture technique affects perianastomotic colonic crypt cell production and tumour formation. Br J Surg 1991;78:671-4.
77. Phillips RK, Cook HT. Effect of steel wire sutures on the incidence of chemically induced rodent colonic tumours. Br J Surg 1986;73:671-4.
78. O'Dwyer PJ, Martin EW. Viable intraluminal tumour cells and local/regional tumour growth in experimental colon cancer. Ann R Coll Surg Engl 1989;71:54-6.
79. McGregor JR, Galloway DJ, Jarrett F, George WD. Anastomotic materials and colorectal carcinogenesis [abstract]. Br J Surg 1988;75:603.
80. Calderisi RN, Freeman HJ. Differential effects of surgical suture materials in 1,2-dimethylhydrazine induced rat intestinal neoplasia. Cancer Res 1984;44:2827-30.
81. McGregor JR, Galloway DJ, McCulloch P, George WD. Anastomotic suture materials and implantation metastases: an experimental study. Br J Surg 1989;76:331-4.
82. O'Dwyer P, Ravikumar TS, Steele G Jr. Serum dependent variability in the adherence of tumour cells to surgical sutures. Br J Surg 1985;72:466-9.
83. Roe R, Fermor B, Williamson RC. Proliferative instability and experimental carcinogenesis at colonic anastomoses. Gut 1987;28:808-15.
84. Williamson RC, Davies PW, Bristol JB, Wells M. Intestinal adaptation and experimental carcinogenesis after partial colectomy. Gut 1982;23:316-25.
85. Rainey JB, Davies PW, Williamson RC. Relative effects of ileal resection and bypass on intestinal adaptation and carcinogenesis. Br J Surg 1984;71:197-202.
86. Rainey JB, Maeda M, Williams C, Williamson RC. The cocarcinogenic effect of intrathecal deoxycholate is reduced by oral metronidazole. Br J Cancer 1984;49: 631-6.
87. Harte PJ, Steele G, Rayner AA, Munroe AE, King VP, Wilson RE. Effects of major small bowel resection on dimethyl hydrazine induced bowel carcinogenesis. J Surg Oncol 1981;18:87-93.
88. Filipe MI, Scurr JH, Ellis H. Effects of fecal stream on experimental colorectal carcinogenesis. Cancer 1982; 50:2859-66.
89. Williamson RC, Rainey JB. The relationship between intestinal hyperplasia and carcinogenesis. Scand J Gastroenterol 1984;19:57-76.
90. Appleton GV, Davies PW, Bristol JB, Williamson RC. Inhibition of intestinal carcinogenesis by dietary supplementation with calcium. Br J Surg 1987;74:523-5.
91. Ross AH, Smith MA, Anderson JR, Small WP. Late mortality after surgery for peptic ulcer. N Engl J Med 1982;307:519-22.
92. Houghton PW, Owen RJ, Henly PJ, Mortensen NJ, Hill MJ, Williamson RC. Experimental colonic carcinogenesis after gastric surgery. Br J Surg 1990;77:774-8.
93. Vannucci L, Huggins CB, Mosca F. A new experimental model for colorectal carcinogenesis in the rat. J Environ Pathol Toxicol Oncol 1994;13:59-61.
94. Bristol JB, Wells M, Williamson RC. Adaptation to jejunoileal bypass promotes experimental colorectal carcinogenesis. Br J Surg 1984;71:123-6.
95. Winsett OE, Townsend CM, Glass EJ, Thompson JC. Gastrin stimulates growth of colon cancer. Surgery 1986;99:302-7.
96. Oscarson JE, Veen VF, Ross JS, Malt RA. Dimethylhydrazine induced colonic neoplasia: dissociation from endogenous gastrin levels. Surgery 1982;91:525-30.
97. Steele G Jr, Sjogren HO, Rosengren JE, Lindstrom C, Larsson A, Leandoer L. Sequential studies of serum blocking activity in rats bearing chemically induced primary bowel tumors. J Natl Cancer Inst 1975;54: 959-67.
98. Mayhew EG, Goldrosen MH, Vaage J, Rustum YM. Effects of liposome entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38. J Natl Cancer Inst 1987;78:707-13.
99. Weese JL, Emoto SE, Sondel PM. Reduced incidence of hepatic metastases by perioperative treatment with recombinant human interleukin-2. Dis Colon Rectum 1987;30:503-7.
100. Lafreniere R, Rosenberg SA. A novel approach to the generation and identification of experimental hepatic metastases in a murine model. J Natl Cancer Inst 1986; 76:309-22.
101. Dawiskiba J, Jeppson B, Persson G, Hagerstrand I, Bengmark S. A model of colonic carcinoma with liver metastases in the rat. J Exp Clin Cancer Res 1983;3: 269-72.
102. Nordlinger B, Panis Y, Puts JP, Herve JP, Delelo R, Ballet F. Experimental model of colon cancer: recurrences after surgery alone or associated with intraperitoneal 5-Fluorouracil chemotherapy. Dis Colon Rectum 1991;34:658-63.
103. Liu DL, Radnall M, Svanberg K, Sefert J. Immunotherapy in liver tumours. III. A new experimental model of metastatic liver tumours from colorectal carcinoma for cytokine therapy. Cancer Lett 1995;88:211-9.
104. Watson SA, Morris TM, Crosbee DM, Hardcastle JD. A hepatic invasive human colorectal xenograft model. Eur J Cancer 1993;29A:1740-5.
105. Berwald Y, Sachs L. In vitro cell transformation with chemical carcinogens. Nature 1963;200:1182-4.
106. Hendrickse CW, Jones CE, Donovan IA, Neoptolemos JP, Baker PR. Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines. Br J Surg 1993;80:636-40.
107. Shawler DL, Dorigo O, Gjerset RA, Royston I, Sobol RE, Fakhrai H. Comparison of gene therapy with interleukin-2 gene modified fibroblasts and tumor cells in the murine CT-26 model of colorectal carcinoma. J Immunother 1995;17:201-8.
108. Purkiss SF, Grahn MF, Turkish M, Macey MG, Williams NS. In vitro modulation of haematoporphyrin derivative photodynamic therapy on colorectal carcinoma multicellular spheroids by verapamil. Br J Surg 1992; 79:120-5.
109. Grahn MF, Turkish M, Rowland AC, Allardice JT, Durdey P, Williams NS. Multicellular tumour spheroids as an in vitro model for photodynamic therapy using haematoporphyrin derivative. Med Sci Res 1988;16: 181-3.
110. Mooney EF, Dye JF, Guillou PJ, Monson JR. Multidrug resistant colonic cancer cell line LoVoDx is efficiently killed by lymphokine activated killer cells from patients with carcinoma of the colon. Br J Surg 1993;80: 1259-61.
111. Sutherland RM. Cell and environmental interactions in tumour microregions: the multicell spheroid model. Science 1988;240:177-84.
112. King TR, Dove WF, Herrmann B, Moser AR, Shedlovsky A. Mapping to a molecular resolution in the T to H-2 region of the mouse genome with a nested set of meiotic recombinants. Proc Natl Acad Sci USA 1989; 86:222-6.
113. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990;247:322-4.
114. Luongo C, Gould KA, Su LK, et al. Mapping of multiple intestinal neoplasia (Min) to proximal chromosome 18 of the mouse. Genomics 1993;15:3-8.
115. Riggins GJ, Markowits S, Wilson JK, Vogelstein B, Kinzler KW. Absence of secretory phospholipase A2 gene alterations in human colorectal cancer. Cancer Res 1995;55:5184-6.
116. Morin PJ, Vogelstein, Kinzler KW. Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 1996;93:7950-4.
117. Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, Gould MN. ApcMin, a mutation in the marine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci U S A 1993; 90:8977-81.
118. Dietrich WF, Lander ES, Smith JS, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993;75:631-9.
119. Kim SH, Roth KA, Moser AR, Gordon JI. Transgenic mouse models that explore the multistep hypothesis of intestinal neoplasia. J Cell Biol 1993;123:877-93.
120. Shoemaker AR, Moser AR, Dove WF. N-ethyl-N- nitrosourea treatment of multiple intestinal neoplasia (Min) mice: age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts. Cancer Res 1995;55:4479-85.
121. Moser AR, Dove WF, Roth KA, Gordon JI. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 1992;116:1517-26.
122. Moser AR, Luongo C, Gould KA, McNeley MK, Shoemaker AR, Dove WF. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer 1995;31A:1061-4.
123. Luongo C, Moser AR, Gledhill S, Dove WF. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 1994;54:5947-52.
124. Levy DB, Smith KJ, Beazer-Barclay Y, Hamilton SR, Vogelstein B, Kinzler KW. Inactivation of both APC alleles in human and mouse tumors. Cancer Res 1994; 54:5953-8.
125. Moser AR, Shoemaker AR, Connelly CS, et al. Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Dev Dyn 1995;203:422-33.
126. Dove WF, Gould KA, Luongo C, Shoemaker AR. Emergent issues in the genetics of intestinal neoplasia. Cancer Surv 1995;25:335-55.
127. Jacoby RF, Marshall DJ, Newton MA, et al. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal antiinflammatory drug piroxicam. Cancer Res 1996;56: 710-4.
128. Beazer-Barclay Y, Levy DB, Moser AR, et al. Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis 1996;17:1757-60.
129. Su LK, Kinzler KW, Vogelstein B, et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992;256:668-70.
130. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA 1995;92:4482-6.
131. Oshima M, Oshima H, Kobayashi M, Tsutsumi M, Taketo MM. Evidence against dominant negative mechanisms of intestinal polyp formation by Apc gene mutations. Cancer Res 1995;55:2719-22.
132. Oshima M, Oshima H, Tsutsumi M, et al. Effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine on intestinal polyp development in Apc delta 716 knockout mice. Mol Carcinog 1996;15;11-7.
133. Oshima M, Takahashi M, Oshima H, et al. Effects of docosahexaenoic acid (DHA) on intestinal polyp development in Apc delta 716 knockout mice. Carcinog 1995;16:2605-7.
134. Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cycloxygenase 2 (COX-2). Cell 1996; 87:803-9.
135. Fodde R, Edelmann W, Yang K, et al. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci USA 1994;91:8969-73.
136. Smits R, Kartheuser A, Jagmohan-Changur S, et al. Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis. Carcinog 1997;18:321-7.
137. Midgley CA, White S, Howitt R, et al. APC expression in normal human tissues. J Pathol 1997;181:426-33.
138. Williams AC, Browne SJ, Yeudal WA, et al. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Oncogene 1993;8: 3063-72.
139. Bracey TS, Miller JC, Preece A, Paraskeva C. Gamma radiation induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild type p53. Oncogene 1995;10:2391-6.
140. Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53 independent pathway: implications for the possible role of dietary fibre in the prevention of large bowel cancer. Int J Cancer 1993;55:498-505.
141. Hague A, Elder DJ, Hicks DJ, Paraskeva C. Apotosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer 1995;60:400-6.
142. Hague A, Moorghen M, Hicks D, Chapman M, Paraskeva C. BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene 1994;9: 3367-70.
143. Mackinnon WB, Huschtscha L, Dent K, Hancock R, Paraskeva C, Mountford CE. Correlation of cellular differentiation in human colorectal carcinoma and adenoma cell lines with metabolite profiles determined by magnetic resonance spectroscopy. Int J Cancer 1994;59:248-61.
144. Singh S, Paraskeva C, Gallimore PH, Sheppard MC, Langman MJ. Differential growth response to oestrogen of premalignant and malignant colonic cell lines. Anticancer Res 1994;14:1037-41.
145. Williams AC, Browne SJ, Maning AM, Daffada P, Collard TJ, Paraskeva C. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor -beta 1. Oncogene 1994;9:1479-85.
146. Williams AC, Hague A, Elder DJ, Paraskeva C. In vitro models for studying colorectal carcinogenesis: cellular and molecular events including APC and Rb cleavage in the control of proliferation, differentiation and apoptosis. Biochem Biophys Acta 1996;1288:9-19.
147. Elder DJ, Hague A, Hicks DJ, Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human clorectal tumour cell lines: enhanced apoptosis in carcinoma and in vitro transformed adenoma relative to adenoma cell lines. Cancer Res 1996;56: 2273-6.
148. Sheehan JK, Thornton DJ, Howard M, Carlstedt I, Corfield AP, Paraskeva C. Biosynthesis of the MUC2 mucin: evidence for a slow assembly of fully glycosylated units. Biochem J 1996;315:1055-60.
149. Vavasseur F, Dole K, Yang J, et al. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem 1994;222:415-24.
150. Hague A, Hicks DJ, Bracey TS, Paraskeva C. Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: growth factors protect against c-myc independent apoptosis. Br J Cancer 1997;75: 960-8.
151. Brunton VG, Ozanne BW, Paraskeva C, Frame MC. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer. Oncogene 1997;14: 283-93.
152. Empereur S, Djelloul S, Di Gioia Y, et al. Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasion. Br J Cancer 1997;75:241-50.
153. Browne SJ, Williams AC, Hague A, Butt AJ, Paraskeva C. Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low molecular weight form is associated with apoptosis in vitro. Int J Cancer 1994;59:56-64.
154. Williams AC, Hague A, Manning AM, Van der Stappen JW, Paraskeva C. In vitro models of human colorectal cancer. Cancer Surv 1993;16:15-29.
155. Cowen SE, Bibby MC, Double JA. Characterisation of the vasculature within a murine adenocarcinoma growing in different sites to evaluate the potential of vascular therapies. Acta Oncol 1995;34:357-60.
156. Burger AM, Double JA, Konopa J, Bibby MC. Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer. Br J Cancer 1996;74:1369-74.
157. Steele G, Sjoegren HO, Price MR. Tumor-associated and embryonic antigens in soluble fractions of a chemically-induced rat colon carcinoma. Int J Cancer 1975; 16:33-51.
158. Steele G, Sjoegren HO. Cell surface antigens in a rat colon cancer model: correlation with inhibition of tumor growth. Surgery 1977;82:164-9.
159. Rogers AE, Gildin J. Effect of BCG on dimethylhydrazine induction of colon tumors in rats. J Natl Cancer Inst 1975;55:385-91.
160. Hill MJ, Aries VC. Faecal steroid composition and its relationship to cancer of the large bowel. J Pathol 1971;104:129-39.
161. Nigro ND, Singh DV, Campbell RL, Sook M. Effect of dietary beef fat on intestinal tumor formation by azoxymethane in rats. J Natl Cancer Inst 1975;54:439-42.
162. Reddy BS, Narisawa T, Vukusich D, Weisburger JH, Wynder EL. Effect of quality and quantity of dietary fat and dimethylhydrazine in colon carcinogenesis in rats. Proc Soc Exp Biol Med 1976;151:237-9.
163. Reddy BS, Watanabe K, Weisburger JH. Effect of highfat diet on colon carcinogenesis in F344 rats treated with 1,2-dimethylhydrazine, methylazoxymethanol acetate, or methylnitrosourea. Cancer Res 1977;37: 4156-9.
164. Reddy BS, Weisburger JH, Wynder EL. Effects of dietary fat level and dimethylhydrazine on fecal acid and neutral sterol excretion and colon carcinogenesis in rats. J Natl Cancer Inst 1974;52:507-11.
165. Reddy BS, Mangat S, Weisburger JH, Wynder EL. Effect of high risk diets for colon carcinogenesis on intestinal mucosal and bacterial b-glucuronidase activity in F344 rats. Cancer Res 1977;37:3533-6.
166. Reddy BS, Narisawa T, Wright P, Vukusich D, Weisburger JH, Wynder EL. Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res 1975;35:287-90.
167. Cohen BI, Raicht RF, Deschner EE, Takahashi M, Sarwal AN, Fazzi E. Effect of cholic acid feeding on n-methyl-n-nitrosurea induced colon tumours and cell kinetics in rats. J Natl Cancer Inst 1980;64:573-8.
168. Banerjee AK. DCC expression and prognosis in colorectal cancer [editorial]. Lancet 1997;349:968.